Biotechnology, SCOTUS | JD Supra Law News

Bowman v. Monsanto: Self-Replicating Biotech and Software Left at the Alter?

by Robert Isackson | Orrick, Herrington & Sutcliffe LLP on 5/15/2013

Today, in a case having the potential to upset the agricultural biotech industry, Justice Elena Kagan delivered the U.S. Supreme Court’s unanimous decision rejecting farmer Vernon Hugh Bowman’s patent exhaustion defense....more

Legal Alert: Monsanto Ruling Protects Innovators of Self-Replicating Biotechnology

by William Warren, David Wigley, Ph.D. | Sutherland Asbill & Brennan LLP on 5/15/2013

On May 13, 2013, a unanimous U.S. Supreme Court held in Monsan to v. Bowman that the doctrine of patent exhaustion does not permit a farmer to reproduce patented seeds for planting and harvesting without the patent holder's...more

[Legal Perspective] Can Human Genes Be Patented?

by JD Supra Law News on 4/24/2013

Earlier this month, the United States Supreme Court heard oral arguments in a case that comes down to a single question: can human genes be patented?...more

Can You Patent Human Genes? ACLU Says No [Video]

by Bloomberg Law on 4/12/2013

April 12 (Bloomberg Law) -- On April 15, 2013, the United States Supreme Court will hear oral arguments for Association for Molecular Pathology v. Myriad Genetics, Inc. The case centers on whether patents may be granted on...more

Briefing the Supreme Court in Myriad

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 3/29/2013

March 15, 2013 was a big deadline for patent applicants seeking to secure first-to-invent filing dates for U.S. patent applications, but April 15 will be a big day for the biotechnology industry, when the Supreme Court hears...more

Supreme Court To Hear Oral Arguments in Landmark Patent Case

by Baker, Donelson, Bearman, Caldwell &... on 3/28/2013

April 15 is a big day for biotechnology, pharmaceutical, and medical diagnostic companies at the Supreme Court, as justices begin a new session by hearing oral arguments in a landmark case involving the patentability of...more

It Ain't Necessarily So Down on the Farm: Not All Farmers Agree with Farmer Bowman in Bowman v. Monsanto

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 2/1/2013

The "conventional wisdom" surrounding the Bowman v. Monsanto case now before the Supreme Court on certiorari is that it is "David v. Goliath," the salt-of-the-earth farmer versus the corporate monolith, and an example of the...more

IPO Files Amicus Brief in Support of Respondents in Bowman v. Monsanto

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 1/25/2013

In an amicus brief filed in support of respondents Monsanto Co. et al. late last week, the Intellectual Property Owners Association (IPO) urges the Supreme Court to find that the petitioner's replanting of commodity seed was...more

Is It Time for Myriad to Concede in AMP v. Myriad for the Good of the Biotechnology Industry?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 1/24/2013

The Supreme Court's grant of certiorari over the question "Are human genes patentable" had raised for many the specter of an uninformed generalist court rendering a decision containing dicta that would negatively affect...more

“Are Human Genes Patentable?” The Supreme Court Grants Certiorari in Myriad

by Randy V. Clower | Phillips Lytle LLP on 12/20/2012

On November 30, 2012, the Supreme Court granted certiorari – in what portends to be one of the most impactful decisions in patent law history – to end the “gene patenting” debate, an issue that lower courts have measured over...more

Supreme Court to Consider Whether (Isolated) Human Genes are Patentable

by Lars H. Genieser, Ph.D., Fabian M. Koenigbauer | Venable LLP on 12/19/2012

On November 30, 2012, the U.S. Supreme Court agreed to decide a case presenting the seemingly simple, but legally complex, question, “Are human genes patentable?” After Bilski v. Kappos, 130 S. Ct. 3218 (2010) and Mayo...more

Sound the Alarm?—The Supreme Court’s Renewed Interest in Life Sciences Patents Could Create Additional Hurdles Across the Field

by Morrison & Foerster LLP on 11/19/2012

First, there was Mayo v. Prometheus, where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter. Then, the Court sent Myriad back to the Federal Circuit, for further consideration...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Biotechnology › SCOTUS

Bowman v. Monsanto: Self-Replicating Biotech and Software Left at the Alter?

Legal Alert: Monsanto Ruling Protects Innovators of Self-Replicating Biotechnology

[Legal Perspective] Can Human Genes Be Patented?

Can You Patent Human Genes? ACLU Says No [Video]

Briefing the Supreme Court in Myriad

Supreme Court To Hear Oral Arguments in Landmark Patent Case

It Ain't Necessarily So Down on the Farm: Not All Farmers Agree with Farmer Bowman in Bowman v. Monsanto

IPO Files Amicus Brief in Support of Respondents in Bowman v. Monsanto

Is It Time for Myriad to Concede in AMP v. Myriad for the Good of the Biotechnology Industry?

“Are Human Genes Patentable?” The Supreme Court Grants Certiorari in Myriad

Supreme Court to Consider Whether (Isolated) Human Genes are Patentable

Sound the Alarm?—The Supreme Court’s Renewed Interest in Life Sciences Patents Could Create Additional Hurdles Across the Field

Supreme Court Decision: Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.

Will SCOTUS Rewrite the Standard for Patent Invalidity?

Bilski v. Kappos: Effects on Biotechnology Patents

Can You Patent Human Genes? ACLU Says No [Video]

Expand Your Reach